Page 99 - Cardiac testing for coronary artery disease in potential kidney transplant recipients
P. 99
* P values for this variable were calculated using the likelihood ratio test in SAS (PROC NLMIXED), and represented the final P value
obtained from a backward elimination approach used to eliminate non-significant terms from the original hierarchical model.
Table 4. Comparison of systematic reviews studying the test performance of myocardial perfusion scintigraphy and dobutamine
stress echocardiography
Review Population DSE MPS
Sensitivity (95% Specificity (95% Sensitivity (95% Specificity (95%
CI) CI) CI) CI)
Cochrane review Kidney transplant 0.79 (0.67 to 0.88) 0.89 (0.81 to 0.94) 0.74 (0.54 to 0.87) 0.70 (0.51 to 0.84)
candidates only
Fleischmann 1998 General population 0.85 (0.83 to 0.87) 0.77 (0.74 to 0.80) 0.87 (0.86 to 0.88) 0.64 (0.60 to 0.68)
Schinkel 2003 General population 0.80 (NS) 0.86 (NS) 0.84 (NS) 0.77 (NS)
DSE: dobutamine stress echocardiography; MPS; myocardial perfusion scintigraphy; NS - not stated
A P P E N D I C E S
Appendix 1. Electronic search strategies
Database Search terms
MEDLINE 1. Kidney Transplantation/
2. Pancreas Transplantation/
3. (kidney and pancreas and (transplant$ or graft$)).tw.
4. Kidney Failure/
5. Kidney Failure, Chronic/
6. (chronic kidney or chronic renal).tw.
7. (endstage kidney or endstage renal).tw.
8. (end stage kidney or end stage renal).tw.
9. (ESRD or ESKD or ESRF or ESKF).tw.
10. exp Renal Dialysis/
11. dialysis.tw.
12. (hemodialysis or haemodialysis).tw.
13. (hemodiafilt$ or haemodiafilt$).tw.
14. (hemofilt$ or haemofilt$).tw.
15. (PD or CAPD or CCPD or APD).tw.
16. or/1-15
Cardiac testing for coronary artery disease in potential kidney transplant recipients (Review) 97
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.